Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia Vol. 24; p. S223
Main Authors: Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Saleh, Othman, Al-Hawi, Omar, Abdallah, Mohamed, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar
Format: Journal Article
Language:English
Published: Elsevier Inc 01-09-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2152-2650
DOI:10.1016/S2152-2650(24)00862-0